Get notified when SUPN files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SUPN SUPERNUS PHARMACEUTICALS, INC. 8-K

Supernus schedules Q1 2026 earnings release for May 5 after market close

Filed April 22, 2026 · Period ending April 22, 2026 · ~1 min read

Key Changes

  • low

    Company will report first quarter 2026 financial and business results after market close on Tuesday, May 5, 2026, followed by a conference call and webcast at 4:30 p.m. ET with CEO Jack Khattar and CFO Tim Dec.

    Item 2.02 — Results of Operations and Financial Condition verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CHAR 10-Q) is open in full — no account needed.

Partner

Trade SUPN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 19, 2026 10:36 PM